Stem cells injected into the eye aim to restore vision in dry AMD trial
Disease control
Recruiting now
This early-phase study tests a stem cell therapy called ASP7317 for people with geographic atrophy, the advanced form of dry age-related macular degeneration that causes central vision loss. The treatment involves injecting special cells under the retina to replace damaged ones. …
Phase: PHASE1 • Sponsor: Astellas Institute for Regenerative Medicine • Aim: Disease control
Last updated May 26, 2026 12:03 UTC